sitagliptin
Commercial- Indications
- Type 2 diabetes
Company intelligence / Profile preview
Grupo Alter
Madrid, Comunidad de Madrid, Spainalter.es ↗
- Ownership
- Private
- Employees
- ~795
- Development stage
- Commercial
01
Overview
Grupo Alter is a commercial pharmaceutical company with over 75 years of experience in healthcare, distributing products across all continents
- Modalities
- Pharmaceutical products
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Strategic alliances with reputable companies to offer innovative added value products
Beyond the preview
Go deeper on Grupo Alter.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grupo Alter.